Introduction
============

Rationale
---------

Both tuberculosis (TB) and parasitic diseases in humans are infectious diseases that exhibit an extensive distribution, causing serious harm to humans. The World Health Organization Special Programme for Research and Training in Tropical Diseases (WHO TDR) provided the TDR disease portfolio in 1999 to deal with the deterioration in the health situation, including leprosy, TB and eight kinds of parasitic diseases, such as malaria, schistosomiasis, etc. \[[@B1]\]. WHO estimated that there was about one third of the global population infected by TB, and in 2010, there were an estimated 8.8 million incident cases of TB globally, mostly occurring in Asia (59%) and Africa (26%) \[[@B2]\]. Meanwhile, in 2009 WHO also reported that there were an estimated 225 million malaria cases, mainly distributed in Africa (78%), South-East Asia (15%) and the Eastern Mediterranean (5%) \[[@B3]\]. In 2012, there were an estimated 436 million people at risk of *Schistosomiasis haematobium* infection in Sub-Saharan Africa, of which 112 million were infected, with an estimated 393 million people at risk of *Schistosomiasis mansoni* infection, of which 54 million were infected \[[@B4]\]; an estimated 120 million people in tropical and subtropical areas of the world were infected with lymphatic filariasis in 2009 \[[@B5]\]. These figures suggest that there is an overlap of endemic regions between TB and parasitic disease, which may lead to co-infection of these diseases in the population.

The earliest report we found was from 1945 and interpreted how to treat a pulmonary TB (PTB) case running concurrently with malaria \[[@B6]\]. A report from 1946 described co-existence of TB with hookworm \[[@B7]\]. The co-infection of TB and parasitic diseases have been reported in many studies for almost the past 70 years, although great achievements have been gained in the fields of TB and parasitic disease control and prevention respectively \[[@B2]-[@B5]\]. Up to 2012, some cases of co-infection between TB and parasitic diseases were reported around the world \[[@B8]-[@B29]\], and some epidemiological surveys of co-infection in hospitals or communities were carried out \[[@B30]-[@B34]\]. Some of these studies showed that the immune response was modified in the co-infection situation \[[@B35]-[@B51]\].

Inevitably, co-infection would increase the complexity of control and prevention on TB and parasitic diseases. The current systematic reviews on the co-infection of TB and parasitic diseases help to clarify the complexity of co-infections; however, there are only a few systematic reviews on co-infection. We only found that Enwere *et al.*\[[@B35]\] reviewed the host response of co-infection between TB and malaria and 4 reviews focused on the influence of chronic helminth infections on immunity against TB \[[@B44],[@B45],[@B47],[@B48]\].

Objectives
----------

This paper reviewed studies globally over the past 70 years on the co-infection of TB and parasitic diseases using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines \[[@B52]\], in order to learn more about which parasites are concurrent with TB, the epidemiological situation regarding co-infection, and the human immune function affected by co-infection.

Methods
=======

Protocol and registration
-------------------------

We did not register the protocol for this review.

Eligibility criteria
--------------------

Published articles were included if they involved case reports of co-infection with TB and any parasitic diseases in human participants, or epidemiological surveys of co-infection in populations, or clinical or laboratory research on the immune responses during co-infection, were eligible for inclusion in the systematic review. Journal articles published with full text or abstracts in English before 2013 were eligible for inclusion.

Information sources
-------------------

We mainly searched PubMed via the NCBI Entrez system (any date to December, 2012) (<http://www.ncbi.nlm.nih.gov>) for studies on the association between TB and parasitic diseases. We also searched bibliographies of identified reports, including previous reviews, for additional references.

Search
------

The search was limited to studies of human beings or animal models and no language limits were applied. The terms that were used as MeSH terms or Direct keywords for the search and our search strategy are described in Table [1](#T1){ref-type="table"}. All titles, abstracts and full texts from each of the searches were examined and reviewed.

###### 

Search strategy and terms used to identify studies on co-infection between TB and common parasitic diseases

  **Term**       1\. tuberculosis, 2. parasite, 3. helminth, 4. amoebiasis, 5. leishmaniasis, 6. trypanosomiasis, 7. giardiasis, 8. trichomoniasis, 9. malaria, 10. toxoplasmosis, 11. cryptosporidiosis, 12. clonorchiasis, 13. opisthorchiasis, 14. fasciolopsiasis, 15. fascioliasis, 16. paragonimiasis, 17. schistosomiasis, 18. sparganosis, 19. echinococcosis, 20. ascariasis, 21. trichuriasis, 22. enterobiasis, 23. hookworm, 24. strongyloidiasis, 25. trichinellosis, 26. filariasis, 27. dracunculiasis
  -------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Strategy**   1 and (2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27)

Study selection
---------------

The study selection process is illustrated in Figure [1](#F1){ref-type="fig"}.

![Study selection information regarding co-infection between TB and parasitic diseases.](1756-3305-6-79-1){#F1}

Papers that were not co-infection studies, or were not for humans, or were published in non-English language without an abstract in English, were excluded. Eligible papers were tabulated.

Data collection process
-----------------------

Two reviewers extracted data from each eligible study independently, and differences were resolved by discussion with a third. Extracted data was tabulated on the basis of data items. No formal meta-analysis was carried out and analysis to investigate statistical heterogeneity or publication bias was not performed because most of the studies were case reports and immunological research, and there were very few epidemiological surveys.

Data items
----------

Data extracted included country, year, co-infection of diseases, sex, age, human immunodeficiency virus (HIV) test and medical history for case reports. For epidemiological surveys, the detailed information included was country, year, survey site, number of population screened, number of people with PTB, number of people with parasitic disease, number of people co-infected and prevalence. For clinical or laboratory research on immunity during co-infection, we collected detailed information on country, year, co-infection of disease, subject and conclusions.

Summary measures
----------------

Risk ratios (RR) and their 95% confidence intervals (CI) were calculated using the Statistical Analysis System (SAS 9.2; SAS Institute Inc., Cary, NC, USA) through Chi square test. All *P*-values of \<0.05 were taken as statistically significant.

Results
=======

Two hundred and eighty nine papers were retrieved from the search of published work, of which, 10 were excluded because of duplication and 235 were irrelevant to co-infection with TB and parasitic diseases. Finally, 44 studies of co-infection were included in the analysis, of which, 22 were case reports, 5 were epidemiological surveys and 17 were immunological research/reviews (Figure). There was no grey literature included.

Table [2](#T2){ref-type="table"} summarizes the case reports of co-infection. Twenty-four cases were reported in 22 studies from 13 countries during 1984 to 2012, in which 7 cases were from India. Fourteen studies investigated co-infection with PTB and parasites diseases and 8 studies involved the extrapulmonary TB, such as renal TB, lymph node TB, abdominal TB, TB in liver, tuberculous lymphadenitis and TB verrucosa cutis. The youngest case reported was 34 days old and the eldest case was 82 years old, and the median age of all cases reported was 36 years old. Fifteen of a total 24 cases were male. Ten patients with different clinical conditions co-infected with TB and leishmaniasis were reported, of which, visceral leishmaniasis was the highest. There were also 6 cases co-infected with TB and hydatid disease. In addition, parasitic diseases accompanied by TB included trichomoniasis, malaria, toxoplasmosis, toxocariasis, schistosomiasis, strongyloidiasis and filarial elephantiasis in different organs. Fourteen of a total of 24 cases reported had been tested for HIV test and 4 were positive.

###### 

Case reports of co-infection between TB and parasitic diseases

  **Country**   **Year of report**   **Tuberculosis**                   **Parasitic disease**                 **Sex**   **Age**    **HIV test**   **Supplement**                                                                                                 **No. of reference**
  ------------- -------------------- ---------------------------------- ------------------------------------- --------- ---------- -------------- -------------------------------------------------------------------------------------------------------------- ----------------------
  Spain         1996                 Renal TB                           Visceral leishmaniasis                Male      44 years   Negative       Haemodialysis for 19 months                                                                                    \[[@B8]\]
  Brazil        2001                 PTB                                Visceral leishmaniasis                Male      29 years   Negative       *Pneumocystis carinii* positive                                                                                \[[@B9]\]
  Turkey        2003                 PTB                                Visceral leishmaniasis                Male      39 years   Negative       Renal transplantation in 2001; Anti-HCV and HCV RNA positive                                                   \[[@B10]\]
  India         2005                 PTB                                Visceral leishmaniasis                Male      37 years   Positive       Tuberculoma of brain                                                                                           \[[@B11]\]
  India         2006                 PTB                                Visceral leishmaniasis                Female    40 years   Positive                                                                                                                      \[[@B12]\]
  India         2006                 PTB                                Visceral leishmaniasis                Male      40 years   Positive                                                                                                                      \[[@B12]\]
  Colombia      1996                 PTB                                Mucocutaneous leishmaniasis           Male      50 years   Negative                                                                                                                      \[[@B13]\]
  France        2003                 PTB                                Cutaneous leishmaniasis               Male      44 years   Negative       A migrant from Brazil; Polar lepromatous leprosy                                                               \[[@B14]\]
  Sri Lanka     2010                 Extrapulmonary TB                  Mucosal leishmaniasis                 Male      52 years   Negative       T-lymphocyte subsets: CD3-437, CD4-237, CD8-146 μl; Serum IgG-532 and IgM-36 mg/dl                             \[[@B15]\]
  India         2010                 PTB                                Post-kala-azar dermal leishmaniasis   Female    25 years   Positive       On treatment for leprosy and PTB for the past 2 months                                                         \[[@B16]\]
  France        2000                 Lymph node TB                      Lymph node trichomoniasis             Female    82 years   Negative                                                                                                                      \[[@B17]\]
  India         2010                 PTB                                Perinatal falciparum malaria          Female    34 days    Unknown        Maternal history of falciparum malaria during eighth month of pregnancy; Father was smear-positive PTB case.   \[[@B18]\]
  Haiti         1984                 PTB                                Toxoplasmosis                         Male      27 years   Unknown        Toxoplasmosis proved fatal and was diagnosed only at autopsy.                                                  \[[@B19]\]
  Sri Lanka     2011                 Lymph node TB                      Toxoplasmosis Toxocariasis            Male      4 years    Negative                                                                                                                      \[[@B20]\]
  Korea         2012                 Disseminated TB                    Cerebral toxoplasmosis                Male      24 years   Unknown        A non-Korean engineer with abdominal TB                                                                        \[[@B21]\]
  Australia     2001                 PTB Tuberculous lymphadenitis      Hepatosplenic schistosomiasis         Male      30 years                  A migrant from the Philippines; A history of alcohol abuse                                                     \[[@B22]\]
  India         1991                 PTB                                Hydatid disease                       Female    5 years    Unknown                                                                                                                       \[[@B23]\]
  Turkey        2002                 PTB                                Cardiac hydatid cyst                  Female    52 years   Negative                                                                                                                      \[[@B24]\]
  China         2004                 TB in liver and abdominal cavity   Liver multiple hydatidosis            Female    28 years   Negative                                                                                                                      \[[@B25]\]
  Sudan         2009                 PTB                                Hydatid disease                       Female    25 years   Unknown        In a solitary pulmonary nodule of left lower lobe                                                              \[[@B26]\]
  China         2009                 PTB                                Liver echinococcosis                  Male      18 years   Unknown        PTB was previously confirmed in 2000 and found relapse in 2008.                                                \[[@B27]\]
  China         2009                 PTB                                Liver echinococcosis                  Female    36 years   Unknown        PTB was previously confirmed in 1998 and found relapse in 2008.                                                \[[@B27]\]
  Britain       1994                 PTB                                Strongyloidiasis Giardiasis           Male      31 years   Unknown        A migrant from Gambia; Being resident in the United Kingdom for two years                                      \[[@B28]\]
  India         2001                 TB verrucosa cutis                 Filarial elephantiasis                Male      55 years   Unknown                                                                                                                       \[[@B29]\]

Abbreviations: HIV = human immunodeficiency virus; PTB = pulmonary tuberculosis; HCV = hepatitis C virus; RNA = ribonucleic acid; CD = cluster of differentiation; Ig = immunoglobulin.

It can be seen in Table [3](#T3){ref-type="table"} that 5 studies from 3 East African countries and 1 East Asian country were conducted for epidemiology of co-infection between TB and parasitic diseases during 1984 to 2012. Two studies screened across the general population with 382 and 782 participants in a community and a hospital respectively, one study showed 329 and 215 PTB patients in two hospitals respectively, one study showed 309 PTB patients who were HIV positive and 346 who were HIV negative in a hospital, in the other study, there were 112 smear positive TB patients in a town, whose parasite species involved *Entamoeba histolytica*, *Leishmania donovani*, *Giardia lamblia*, malaria, *Clonorchis sinensis*, *Schistosoma mansoni, taenia* species, *Ascaris lumbricoides*, *Trichocephalus trichiurus*, hookworm and *Strongyloides stercoralis*. The prevalence of co-infection between TB and parasitic diseases varied widely among different participants, s species or survey sites.

###### 

Epidemiological surveys of co-infection between TB and parasitic diseases

  **Country**   **Year of report**   **No. of population screened (a)**   **No. of people with TB (b)**   **People with parasitic disease (c)**   **No. of people co-infected (d)**   **Prevalence (%)**   **Survey site**   **HIV test**   **No. of reference**                                                                
  ------------- -------------------- ------------------------------------ ------------------------------- --------------------------------------- ----------------------------------- -------------------- ----------------- -------------- ---------------------- ----------- ------------------------------------------------ ------------
  Korea         1984                                                      329                                                                     *Trichocephalus trichiurus*         68                                     20.7                                  Hospital1   Unknown                                          \[[@B30]\]
                                                                          215                                                                     *Trichocephalus trichiurus*         14                                     6.5                                   Hospital2   Unknown                                           
                                                                          329                                                                     *Clonorchis sinensis*               58                                     17.6                                  Hospital1   Unknown                                           
                                                                          215                                                                     *Clonorchis sinensis*               13                                     6.0                                   Hospital2   Unknown                                           
  Sudan         2004                 382                                  100                             252                                     *Leishmania donovani*               77                   20.2              77.0           30.6                   Community   Unknown                                          \[[@B31]\]
  Ethiopia      2006                 782                                  100                             234                                     Intestinal parasites                32                   4.1               32.0           13.7                   Hospital    Unknown                                          \[[@B32]\]
                                     782                                  100                             155                                     Helminths                           16                   2.0               16.0           10.3                   Hospital    Unknown                                           
                                                                                                                                                  Parasites species                                                                                                                                                              
                                     782                                  100                             88                                      *Ascaris lumbricoides*              5                    0.6               5.0            5.7                    Hospital    Unknown                                           
                                     782                                  100                             70                                      *Giardia lamblia*                   15                   1.9               15.0           21.4                   Hospital    Unknown                                           
                                     782                                  100                             50                                      *Entamoeba histolytica*             10                   1.3               10.0           20.0                   Hospital    Unknown                                           
                                     782                                  100                             36                                      Hookworm                            6                    0.8               6.0            16.7                   Hospital    Unknown                                           
                                     782                                  100                             25                                      Taenia species                      2                    0.3               2.0            8.0                    Hospital    Unknown                                           
                                     782                                  100                             13                                      *Strongyloides stercoralis*         5                    0.6               5.0            38.5                   Hospital    Unknown                                           
                                     782                                  100                             8                                       *Trichuris trichiura*               1                    0.1               1.0            12.5                   Hospital    Unknown                                           
  Tanzania      2007                                                      309                                                                     Malaria                             19                                     6.1                                   Hospital    HIV positive                                     \[[@B33]\]
                                                                          309                                                                     Schistosomiasis                     100                                    32.4                                  Hospital    HIV positive                                      
                                                                          309                                                                     Hookworm                            33                                     10.7                                  Hospital    HIV positive                                      
                                                                          346                                                                     Malaria                             9                                      2.6                                   Hospital    HIV negative                                      
                                                                          346                                                                     Schistosomiasis                     132                                    38.2                                  Hospital    HIV negative                                      
                                                                          346                                                                     Hookworm                            86                                     24.9                                  Hospital    HIV negative                                      
  Ethiopia      2012                                                      112                                                                     Intestinal helminths                32                                     28.6                                  Community   47% (53/112) of PTB patients were HIV positive   \[[@B34]\]
                                                                          112                                                                     *Ascaris lumbricoides*              12                                     10.7                                  Community                                                    
                                                                          112                                                                     Hookworm                            8                                      7.1                                   Community                                                    
                                                                          112                                                                     *Schistosoma mansoni*               6                                      5.4                                   Community                                                    
                                                                          112                                                                     *Trichuris trichiura*               8                                      7.1                                   Community                                                    
                                                                          112                                                                     *Strongyloides stercoralis*         3                                      2.7                                   Community                                                    

The interrelationship of infection with TB and parasitic diseases have been evaluated in Table [4](#T4){ref-type="table"} through two studies screened in the general population, with 382 and 782 participants in a community and a hospital respectively. Those who were *Leishmania donovani* positive, *Giardia lamblia* positive or *Strongyloides stercoralis* positive more easily suffered from PTB than those who were negative and RR values (95% CI) were 1.73 (1.14-2.62), 1.80 (1.10-2.93) and 3.11 (1.53-6.35), respectively. Likewise, persons with PTB were more easily infected by *Leishmania donovani*, *Giardia lamblia* or *Strongyloides stercoralis* than persons without PTB and RR values (95% CI) were 1.24 (1.08-1.43), 1.86 (1.09-3.16) and 4.26 (1.42-12.77), respectively.

###### 

The interrelationship of infection between TB and parasitic diseases

  **Country**   **Year of report**   **Parasitic disease**                  **PTB (+)**         **PTB (−)**   **RR**~**row**~**(95% CI)**   ***P*-value**   **No. of reference**
  ------------- -------------------- --------------------------------- ---- ------------------- ------------- ----------------------------- --------------- ----------------------
  Sudan         2004                 *Leishmania donovani*             \+   77                  175           1.73 (1.14-2.62)                              \[[@B31]\]
                                                                       \_   23                  107           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        1.24 (1.08-1.43)    1.00                                        0.0067           
  Ethiopia      2006                 Intestinal parasites              \+   32                  202           1.10 (0.74-1.63)                              \[[@B32]\]
                                                                       \_   68                  480           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        1.08 (0.79-1.47)    1.00                                        0.6272           
                                     Helminths                         \+   16                  139           0.77 (0.46-1.28)                               
                                                                       \_   84                  543           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        0.78 (0.49-1.26)    1.00                                        0.3047           
                                     *Ascaris lumbricoides*            \+   5                   83            0.42 (0.17-0.99)                               
                                                                       \_   95                  599           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        0.41 (0.17-0.99)    1.00                                        0.0341           
                                     *Giardia lamblia*                 \+   15                  55            1.80 (1.10-2.93)                               
                                                                       \_   85                  627           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        1.86 (1.09-3.16)    1.00                                        0.0233           
                                     *Entamoeba histolytica*           \+   10                  40            1.63 (0.90-2.93)                               
                                                                       \_   90                  642           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        1.70 (0.88-3.30)    1.00                                        0.1145           
                                     Hookworm                          \+   6                   30            1.32 (0.62-2.81)                               
                                                                       \_   94                  652           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        1.36 (0.58-3.19)    1.00                                        0.4451^\*^       
                                     *Taenia species*                  \+   2                   23            0.62 (0.16-2.36)                               
                                                                       \_   98                  659           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        0.59 (0.14-2.48)    1.00                                        0.7594^\*^       
                                     *Strongyloides stercoralis*       \+   5                   8             3.11 (1.53-6.35)                               
                                                                       \_   95                  674           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        4.26 (1.42-12.77)   1.00                                        0.0172^\*^       
                                     *Trichuris trichiura*             \+   1                   7             0.98 (0.15-6.17)                               
                                                                       \_   99                  675           1.00                                           
                                     **RR**~**col**~**(95**% **CI)**        0.97 (0.12-7.84)    1.00                                        1.0000^\*^       

+: infected; -: noninfected; \*: Fisher's exact test; Abbreviation: PTB = pulmonary tuberculosis; RR = risk ratio; CI = confidence interval.

Immunological research of co-infection between TB and parasitic diseases during 1989 to 2012 are shown in Table [5](#T5){ref-type="table"}. In four studies that reported a change of activity of the host's immune system when the course of TB was aggravated by opisthorchiasis invasion, the activity increased at the acute stage of invasion and decreased at the subacute stage or in the chronization. A study from France showed that co-infecton of American cutaneous leishmaniasis, lepromatous leprosy and PTB downregulated the T-helper (Th) 1 cell response. Four studies on co-infection with *Mycobacterium tuberculosis* (M. TB) and malaria showed that malarial parasites decreased the host's effective humoral and cellular immune responses to M. TB, and co-infection exacerbated chronic TB, suggesting a competitive antagonist effect between heat shock protein 70 (HSP70) from M. TB and adenosine triphosphate-binding protein (ATPBP) of malaria may exist. Two studies suggested that the impact of co-infection between filarial infection and M. TB infection on the immune response was uncertain. Four studies reported immunomodulation characteristics of co-infection beween TB and intestinal helminths. A study from China indicated that as the echinococcosis chronicity increased, the immune profile in TB patients changed from a Th1 to Th2 response. In three other studies in which the effect of infection of intestinal parasites and *Schistosoma mansoni* on the protective immune response to Bacillus Calmette-Guerin (BCG) vaccination against M. TB and the effect of malaria infection on the effectiveness of novel TB vaccines in protecting against TB were evaluated, the protective efficacy of BCG vaccination was reduced but the effectiveness of novel TB vaccines was unaffected.

###### 

Immunological research of co-infection between TB and parasitic diseases

  **Country**   **Year of report**   **Tuberculosis**                           **Parasitic disease/species**                                                      **Subject**                                                                                                                         **Conclusions**                                                                                                                                                                                                                                                                                                                                                **No. of reference**
  ------------- -------------------- ------------------------------------------ ---------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------
  France        2003                 PTB                                        American cutaneous leishmaniasis                                                   A 44-year-old man with triple infection of cutaneous leishmaniasis, lepromatous leprosy, and PTB                                    Unresponsiveness to IL-12 of patient's T cells after stimulation with *Leishmania guyanensis*, M*. bovis bacille* Calmette-Guerin, and M*.* leprae antigens suggested the inability to mount an appropriate Th cell response to upregulate the IL-12 receptor expression.                                                                                      \[[@B14]\]
  Gambia        1999                 M. TB                                      Malaria                                                                            Review                                                                                                                              Malarial parasites can decrease their vertebrate host's effective humoral and cellular immune responses to M. TB.                                                                                                                                                                                                                                              \[[@B35]\]
  USA           2004                 M. TB                                      *Plasmodium yoelii* NL                                                             Mice                                                                                                                                Co-infected mice were less able to contain growth of M. TB in lung, spleen, and liver and had increased mortality.                                                                                                                                                                                                                                             \[[@B36]\]
  Thailand      2006                 M. TB                                      *Plasmodium falciparum*                                                            HSP70 (M. TB) and ATPBP (*Plasmodium falciparum*)                                                                                   HSP70 and ATPBP share a common molecular function as ATP binding resulting from purine nucleotide binding. Therefore, a competitive antagonist effect between both molecules can be expected.                                                                                                                                                                  \[[@B37]\]
  Germany       2012                 M. TB                                      *Plasmodium berghei* NK65                                                          An experimental mouse model of co-infection                                                                                         Co-infection exacerbated chronic TB while rendering mice less refractory to *Plasmodium*. Co-infected animals presented with enhanced inflammatory immune responses as reflected by exacerbated leukocyte infiltrates, tissue pathology and hypercytokinemia accompanied by altered T-cell responses.                                                          \[[@B38]\]
  Unknown       1989                 PTB                                        Opisthorchiasis                                                                    173 patients with PTB complicated by opisthorchiasis                                                                                Among them, activity of the α1-proteinase inhibitor was more frequently higher and carriers of two markers i.e. Hp 2--2 and Gc 1--1 were more frequent.                                                                                                                                                                                                        \[[@B39]\]
  Unknown       1992                 PTB                                        Opisthorchiasis                                                                    12 PTB patients concurrent with opisthorchiasis                                                                                     When the course of TB is aggravated by opisthorchiasis invasion, the number of cases of antibacterial therapy intolerance increases and prognosis of the diseases deteriorates. It was shown that the antibacterial and anthelminthic therapy had a favourable clinical and immunologic effect.                                                                \[[@B40]\]
  Unknown       1992                 M. TB                                      Opisthorchiasis                                                                    Animal                                                                                                                              In comparison with the groups of animals with monoinvasion and monoinfection, at the acute invasive phase of mixed pathology (2 weeks) the activity of the host's immune system increases, while the biological activities of both pathogens decrease; however, at the subacute phase (2.5 months), all were contrary respectively.                            \[[@B41]\]
  Russia        2003                 TB                                         Opisthorchiasis                                                                    Golden hamsters with SRBC parasitocenosis                                                                                           In cases of mixed pathology, at the acute stage of invasion, the immune system showed increased responses with respect to specific and heterologous antigens; in the chronization of invasion the formation of antibodies to heterologous antigens (SRBC) and the level of specific antiopisthorchiasis and anti-TB immune responses decreased together.       \[[@B42]\]
  China         2009                 PTB                                        Echinococcosis                                                                     A 18 years old male and a 36 years female                                                                                           As the echinococcosis chronicity increased, the immune profile in both subjects changed from a Th1 to Th2 response. Such an elevated Th2 immune profile, with subsequent suppression of the Th1 immune response, is a common feature of chronic helminth infections.                                                                                           \[[@B27]\]
  USA           2012                 M. TB                                      *Litomosoides sigmodontis*                                                         Cotton rats with chronic *L. sigmodontis* infection and uninfected controls were challenged with M. TB by intranasal inoculation.   Chronic filarial infections do not exacerbate M. TB infection in the cotton rat model. It may be possible to develop worm-derived therapies for autoimmune diseases that do not substantially increase the risk for infections.                                                                                                                                \[[@B43]\]
  USA           2012                 M. TB                                      Filarial infections                                                                Review                                                                                                                              Filarial infections very clearly alter the magnitude and quality of the mycobacteria-specific cytokine responses, responses that have been typically associated with control of these intracellular pathogens.                                                                                                                                                 \[[@B44]\]
  Denmark       2007                 TB                                         Intestinal helminth                                                                Review                                                                                                                              Co-infections cause a range of immunomodulation characterized by enhanced Th2-type cytokine profiles, high IgE levels and upregulated regulatory T-cell activity, as well as chronic immune activation.                                                                                                                                                        \[[@B45]\]
  Brazil        2007                 PTB                                        Intestinal helminth                                                                40 PTB patients and 25 healthy controls                                                                                             Compared to either TB patients or healthy controls, co-infected patients' absolute frequencies of CD3^+^, CD4^+^, CD8^+^, NK T cell and CD4^+^CD25^high^ T cell increased. Differences in CD~4~ T cell frequencies were accompanied by lower IFN-γ and elevated and sustained IL-10 levels in WB cultures from co-infected patients compared to TB patients.   \[[@B46]\]
  Mexico        2012                 TB                                         Helminthic infections                                                              Review                                                                                                                              Helminths very clearly alter the magnitude of the mycobacteria-specific cytokine responses, altering the control of the mycobacteria growth. Mycobacteria-induced immune responses are suppressed by helminth infections.                                                                                                                                      \[[@B47]\]
  USA           2012                 TB                                         Helminths                                                                          Review                                                                                                                              Helminth-induced Th2 and T reg responses impinge on host resistance against M. TB infection. Th1 response is reduced in helminth co-infected hosts. Helminth-induced alternatively activated macrophages contribute to enhanced susceptibility to TB.                                                                                                          \[[@B48]\]
  Brazil        2002                 BCG vaccination                            *Ascaris lumbricoides*, *Entamoeba histolytica*, and *Strongyloides stercoralis*   14 male students aged 12--15 years: 7 having protozoan or helminthic infections and 7 free of intestinal parasites                  Th2-like IL-10 responses induced by intestinal parasites may interfere in BCG-induced Th1-like IFN-γ response. Intestinal parasitic infections may significantly alter the protective immune response to BCG vaccination.                                                                                                                                      \[[@B49]\]
  Sweden        2005                 BCG vaccination to protect against M. TB   *S. mansoni*                                                                       BCG vaccinated mice with prior *S. mansoni* infection                                                                               *S. mansoni* infection reduces the protective efficacy of BCG vaccination against M. TB possibly by attenuation of protective immune responses to mycobacterial antigens and/or by polarizing the general immune responses to the Th2 profile.                                                                                                                 \[[@B50]\]
  USA           2011                 TB vaccines in protecting against M. TB    *Plasmodium yoelii* NL                                                             TB vaccines in a co-infection mouse model of two pathogens                                                                          The effectiveness of novel TB vaccines in protecting against TB was unaffected by a primary malaria co-infection in a mouse model of PTB.                                                                                                                                                                                                                      \[[@B51]\]

Abbreviations: PTB = pulmonary tuberculosis; M*.* leprae = *mycobacterium leprae*; M. TB = *mycobacterium tuberculosis*; SRBC = sheep red blood cells; IL = interleukin; Th = T helper; Treg = T regulatory; NL = non-lethal; HSP = heat shock protein; ATP = adenosine triphosphate; ATPBP = ATP-binding protein; Ig = immunoglobulin; CD = cluster of differentiation; NK = natural killer; IFN = interferon; WB = whole blood; BCG = Bacillus Calmette-Guerin; *L. sigmodontis* = *litomosoides sigmodontis*; *S. mansoni* = *schistosoma mansoni*.

Discussion
==========

This review only found 24 cases of co-infection with TB and parasitic diseases but they distributed widely in 13 countries and covered PTB, extrapulmonary TB, and diseases caused by protozoa and helminths \[[@B8]-[@B29]\]. We also found 5 epidemiological studies in which prevalence of co-infection varied widely \[[@B30]-[@B34]\], and found that it was evident in 18 studies that the activity of the host's immune system was altered during co-infection happened \[[@B27],[@B34]-[@B42],[@B44]-[@B51]\]. Therefore, assessing co-infection characteristics, influencing factors and impact on immunity is important to control and prevention whether for TB or parasitic diseases.

About 17 parasite genera concurrent with M. TB were reviewed as case reports, epidemiological surveys and immunological research, which were divided into protozoa (*Entamoeba*\[[@B32],[@B49]\], *Leishmania*\[[@B8]-[@B16],[@B31]\], *Giardia lamblia*\[[@B28],[@B32]\], *Trichomonas*\[[@B17]\], *Plasmodium*\[[@B18],[@B33],[@B35],[@B37],[@B38]\], *Toxoplasma*\[[@B19]-[@B21]\]) and helminths (*Clonorchis sinensis*\[[@B30]\], *Opisthorchis*\[[@B39],[@B40]\], *Schistosoma*\[[@B22],[@B33],[@B34]\], *Taenia*\[[@B32]\], *Echinococcus*\[[@B23]-[@B27]\], *Ascaris lumbricoides*\[[@B32],[@B34],[@B49]\], *Toxocara*\[[@B20]\], *Trichuris trichiura*\[[@B30],[@B32],[@B34]\], *Ancylostoma*\[[@B32]-[@B34]\], *Strongyloides stercoralis*\[[@B28],[@B32],[@B34],[@B49]\], *Filaria*\[[@B29],[@B43],[@B44]\]) and covered most of the common parasites species. Of those, leishmaniasis, hydatid disease and malaria were reported to coexist more freuequently with TB in the human body. In addition to co-infection of TB and a single parasitic disease, there was also co-infection of TB and multiple parasitic diseases, such as co-infection of pneumocystis carinii pneumonia, visceral leishmaniasis and PTB, co-infection of toxoplasmosis, toxocariasis and TB, and co-infection of strongyloidiasis, giardiasis and TB \[[@B9],[@B20],[@B28]\].

Possibly gender differences exist in co-infection of TB and different parasitic diseases. Among ten cases reported to be co-infected with TB and leishmaniasis, only two cases were female \[[@B8]-[@B16]\], however, only one of six cases co-infected with TB and hydatid disease was male \[[@B23]-[@B27]\]. In spite of these limited data without epidemiological evidence, we can infer that different social roles associated by gender possibly result in different probabilities of contacting different parasites resulting in different incidence and prevalence. An epidemiological survey in subtropical Ecuador suggested that male gender was one of risk factors associated with cutaneous leishmaniasis \[[@B53]\]. Contrarily, a population-based study in the Hamar of Ethiopia indicated that hydatid disease was a public health problem for women \[[@B54]\]. Irrefutably, gender differentials also exist in the prevalence of TB \[[@B55]\].

Although no significant age clustering was found in 23 cases of co-infecion who had a huge age span ranging from 34 days old to 82 years old \[[@B8]-[@B29]\], however, there were fewer reported cases of less than 20 years old and more than 60 years old. Likewise, this limited data were not epidemiological results. Nevertheless, age differentials of co-infection also exist and should not be a neglected factor. A cross-sectional household survey in Sudan showed that percentages of leishmania skin tests and tuberculin positivity by age group increased \[[@B31]\], which possibly reflects that with the increasing age, not only does the immune response increase following exposure to infection but also opportunities of exposure to infection increase gradually.

Among TB patients, prevalence of parasitic disease varies widely in different areas and different survey sites. TB and parasitic disease co-infection is common in clinical practice in East Africa. In Sudan, up to 77% of TB patients were positive for the leishmania skin test in the community \[[@B31]\]; 32% of TB patients from hospitals had intestinal parasites and 29% of TB patients from the community had intestinal helminths in Ethiopia \[[@B32],[@B34]\]; and 32.4-38.2% of TB patients from hospitals were also infected with Schistosomes in Tanzania \[[@B33]\]. We also noticed the prevalence differentials in Korea, where the infection rates of *Trichocephalus trichiurus* and *Clonorchis sinensis* were 20.7% and 17.6% respectively among TB patients in one hospital, but the infection rates were 6.5% and 6.0% respectively in another hospital \[[@B30]\]. Among the PTB patients from a hospital in Tanzania, the HIV-positive patients had a significantly lower prevalence of hookworm and Schistosome infection and a higher prevalence of malaria than the HIV-negative patients \[[@B33]\], which indicates HIV also has an impact on prevalence of co-infection.

Therefore, it is no surprise to find many factors that possibly affect co-infection of TB and parasitic diseases. First, socio-demographics, such as gender and age as previously mentioned above, maybe relate to prevalence of co-infection. Second, some special patients, such as renal transplant recipients, patients on maintenance haemodialysis, HIV positive patients and migrants \[[@B8],[@B10]-[@B12],[@B14],[@B16],[@B21],[@B22],[@B28],[@B33]\], are likely to be susceptible populations of co-infection. Last but not least, there are higher probabilities of co-infection in some areas with a higher prevalence of TB and parasitic diseases, such as India and East Africa \[[@B11],[@B12],[@B16],[@B18],[@B23],[@B29],[@B31]-[@B34]\]. These might provide useful information to control and prevent co-infection of TB and parasites under the background of very few epidemiological surveys for co-infection to date.

It was observed that PTB and parasitic diseases were risk factors for each other. We analyzed the data of an epidemiological survey in Sudan and found that Leishmaniasis patients had a 1.73 times higher risk for PTB than individuals without Leishmania and PTB patients had a 1.24 times higher risk for Leishmaniasis than individuals without PTB \[[@B31]\]. We also found data from an epidemiological survey in Ethiopia that Giardiasis and Strongyloidiasis patients all had higher risks for PTB than persons without *Giardia lamblia* and *Strongyloides stercoralis*, respectively, and PTB patients had a higher risk for Giardiasis and Strongyloidiasis than persons without PTB \[[@B32]\].

In comparison with mono-infection, co-infection makes the host's immune system have to deal with a more complex internal environment. The usual manifestation is that clinical signs might become more frequent and serious and therapy may be affected when TB patients are also infected by parasites. Both clinical and laboratory based studies showed that when the course of TB was aggravated by opisthorchiasis invasion, clinical signs of TB became more pronounced, disorders in the functions of the liver and pancreas became more frequent, antibacterial therapy intolerance increased and prognosis of the disease deteriorated \[[@B39],[@B40]\]. In order to clarify these situations, some studies were conducted to evaluate the immuno-pathogenesis of co-infection. Limited data from two studies showed that the immune response of TB patients increased at the acute stage of opisthorchiasis invasion and decreased at the subacute stage or in the chronization \[[@B41],[@B42]\]. Two studies indicated that malarial parasites decreased the hosts effective humoral and cellular immune responses to M. TB \[[@B35],[@B36]\], and another study using an experimantal animal model showed co-infection between TB and malaria exacerbated chronic TB while rendering mice less refractory to *Plasmodium*\[[@B38]\]. Another study found that with the increase of echinococcosis chronicity, the immune profile in TB patients displayed an elevated Th2 immune reponse with subsequent suppression of the Th1 immune response \[[@B27]\]. Although one study suggested chronic filarial infections do not exacerbate M. TB infection \[[@B43]\], a review pointed out that filarial infections very clearly alter the magnitude and quality of the mycobacteria-specific cytokine response \[[@B44]\]. Generally, it is observed that the host's immune system is inhibitited to a great extent during co-infection.

Some investigations observed the change of levels of immune indexes during co-infection. A study on co-infection of PTB and opisthorchiasis found that among co-infected patients, activity of the α1-proteinase inhibitor was more frequently higher and carriers of two markers i.e. Hp 2--2 and Gc 1--1 were more frequent \[[@B39]\]. A study on triple infection of leishmaniasis, TB and leprosy showed that patients were unable to mount a Th cell response to upregulate the interleukin-12 receptor expression after stimulation of the triple infection \[[@B14]\]. The investigation of co-infection between TB and intestinal helminths suggested that compared to either TB patients or healthy controls, the absolute frequencies of CD3^+^, CD4^+^, CD8^+^, Natural killer T cell and CD4^+^CD25^high^ T cell increased in co-infected patients \[[@B46]\]. Indeed, the change of immune index levels reflects a 'weakened' immune response.

It is worthwhile evaluating the impact of parasitic disease infection on the efficacy of BCG vaccination against M. TB. Ferreira *et al.*\[[@B49]\] and Elias *et al.*\[[@B50]\] found that intestinal parasitic infections might significantly alter the protective immune response to BCG vaccination and/or polarize the general immune response to the Th2 profile since Th2-like interleukin-10 responses induced by intestinal parasites might interfere in the BCG-induced Th1-like interferon-γ response. Therefore, in areas of high prevalence of co-infection, anti-parasitic chemotherapy prior to immunization may greatly enhance the efficacy of BCG vaccination.

Conclusion
==========

This review has found limited evidence of factors that influence epidemic and host's immunity of co-infection between TB and parasitic disease in humans. Most of the common parasites species are concurrent with M. TB in multiple organs, which increase antibacterial therapy intolerance and deteriorate prognosis of disease. Socio-demographics such as gender and age, special populations with susceptibility, such as renal transplant recipients, patient on maintenance haemodialysis, HIV positive patients and migrants, and living in or coming from co-endemic areas likely have impacts on co-infection. PTB and parasitic diseases were shown to be risk factors for each other. Co-infection may inhibit the hosts immune system to a great extent. In addition, infection with parasites can alter the protective immune response to BCG vaccination against M. TB.
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